Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • May 4th, 2012 • Emergent BioSolutions Inc. • Pharmaceutical preparations
This Amendment to Consulting Agreement (the “Amendment”) is effective as of January 1, 2012 (the “Effective Date”) by and between Emergent BioSolutions Inc. (“Emergent”), with a principal office at 2273 Research Blvd. Suite 400 Rockville, MD 20850, and Robert Kramer (“Consultant”), with a principal office at 6872 Oleander Lane Portage, MI 49024.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. CONSULTING AGREEMENTConsulting Agreement • May 4th, 2012 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Maryland
This Consulting Agreement (“Agreement”), effective as of September 6, 2011 (“Effective Date”), is made by and between Emergent BioSolutions Inc. (“Emergent”), with a principal office at 2273 Research Blvd. Suite 400 Rockville, MD 20850, and Robert Kramer (“Consultant”), with a principal office at 6872 Oleander Lane Portage, MI 49024. Emergent and Consultant are hereinafter referred to individually as “Party” or collectively as the “Parties”. The Parties hereby agree as follows:
